Dr. George Mitra joined SAIC-Frederick, Inc. (renamed Leidos Biomedical Research, Inc. in September 2013) as Director of the Biopharmaceutical Development Program, in May 1999 in support of the Biological Resource Branch of the Developmental Therapeutic Program of the National Cancer Institute. As the director of the program, he manages all biological product development and clinical production of natural products, recombinant proteins, monoclonal antibodies, recombinant immunotoxins, plasmid DNA, viral vaccines and other related entities.
Mitra’s previous biotech industry experience includes executive management positions at Smith Kline Beecham’s Vaccine research and development facility at Rixensart, Belgium and Bayer USA’s biological research and development-manufacturing division at Berkeley, California. He has contributed towards development and licensing of numerous biological products (>10 licensed biologicals) and is listed as a discoverer on 20 issued patents. His Ph.D. is in Bio-Chemical Engineering from the University of California at Berkeley, California.
